MR spectroscopy in pediatric neuroradiology

Magnetic Resonance Imaging Clinics of North America

Volumn 9, Issue 1, 2001, Pages 165-189

  Hunter, J V ^a   Wang, Z J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOLEUKODYSTROPHY; BRAIN CANCER; BRAIN DISEASE; BRAIN INFECTION; BRAIN ISCHEMIA; CANCER DIAGNOSIS; CHILD; DIAGNOSTIC VALUE; EPILEPSY; HUMAN; METABOLIC DISORDER; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEDIATRICS; REVIEW; STROKE; WHITE MATTER;

BRAIN; BRAIN CHEMISTRY; BRAIN DISEASES; BRAIN DISEASES, METABOLIC; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM INFECTIONS; CHILD; EPILEPSY; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MENTAL RETARDATION;

EID: 0035050453     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. In vivo evidence of brain galactitol accumulation in an encephalopathic infant with galactosemia
2. In vivo brain myo-inositol levels in children with Down syndrome
3. 13C MRS at 1.5 T
4. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal cerebral lipofuscinosis
5. Clinical application of proton MR spectroscopy
6. Brain lesions in patients with AIDS: H-1 MR Spectroscopy
7. Radiologic-pathologic correlation: Cerebral toxoplasmosis and lymphoma in AIDS
8. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy
9. Proton magnetic resonance spectroscopy and diffusion weighted-MRI in focal brain lesions in AIDS
10. Localized proton MRS of the human hippocampus: Metabolite concentrations and relaxation times
11. Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency
12. Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy
13. Quantitative 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo
14. Multisection proton MR spectroscopic imaging of the brain
15. Perinatal hypoxia-ischemia and brain injury
16. Three-dimensional multivoxel proton MR spectroscopy of the brain in children with neurofibromatosis type 1
17. Total brain N-acetylaspartate: A new measure of disease load in MS
18. Imaging studies in a unique familial dysmyelinating disorder
19. Metabolic and destructive brain disorders in children: Findings with localized proton MR spectroscopy
20. Cerebral lactate and N-acetyl-aspartate/choline ratios in asphyxiated full-term neonates demonstrated in-vivo using proton magnetic resonance spectroscopy
21. Proton MR spectroscopy after acute central nervous system injury: Outcome prediction in neonates, infants, and children
22. Localized 1H NMR measurements of 2-pyrrolidinone in human brain in vivo
23. In vivo detection of GABA in human brain using a localized double-quantum filter technique
24. 1H MR spectroscopy of the basal ganglia in childhood: A semiquantitative analysis
25. Use of brain lactate levels to predict outcome after perinatal asphyxia
26. Diagnostic and prognostic value of cerebral 31-P magnetic resonance spectroscopy in neonates with perinatal asphyxia
27. Proton-decoupled 31P chemical shift imaging of the human brain in normal volunteers
28. Studies of human tumors by MRS: A review
29. Proton MR spectroscopy of the brain in infants
30. Proton magnetic resonance spectroscopy of the brain in normal pre-term and term infants and early changes after perinatal hypoxia-ischemia
31. Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy
32. Estimation of metabolite concentration from localized in vivo proton NMR spectra
33. Localized 1H NMR measurement of gamma-aminobutyric acid in human brain in vivo
34. MR spectroscopy shows reduced frontal lobe concentrations of N-acetyl aspartate in patients with juvenile myoclonic epilepsy
35. Reliable detection of macromolecules in single volume 1H spectra of human brain
36. Proton spectroscopy of suprasellar tumors in pediatric patients
37. Comprehensive MR imaging protocol for stroke management: Tissue sodium concentration as a measure of tissue viability in nonhuman primate studies and in clinical studies
38. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain
39. A new leucoencephalopathy with vanishing white matter
40. Proton MR spectroscopy of pediatric cerebellar tumors
41. Proton MR spectroscopy of pediatric brain metabolic disorders
42. Effects of Vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography
43. 5-lipoxygenase inhibition: A new treatment strategy for Sjögren-Larsson syndrome
44. F-19-MRS studies of fluorinated drugs in humans
45. Magnetic resonance spectroscopy and near infrared spectroscopy in the assessment of the asphyxiated term infant
46. The value of proton MR spectroscopy in pediatric metabolic brain disease